Ovid Announces New Agreement with Neural Regeneration Research, a Medical
Journal Published in China


    
    Neural Regeneration Research will be available exclusively on the OvidSP
    online search and discovery platform to medical and healthcare
institutions
    globally.




    
</pre>
<p>NEW YORK, <chron>Nov. 30</chron> /CNW/ -- As part of ongoing efforts to strengthen its presence in China's healthcare information market, Ovid, a part of Wolters Kluwer Health and a global leader in electronic scientific, medical, and academic information research solutions, is pleased to announce an agreement with Neural Regeneration Research (NRR), an English-language monthly journal dedicated to presenting peer-reviewed, evidence-based scholarly research in stem cells and regeneration. NRR will be available exclusively on OvidSP, via the OvidSP electronic search and discovery platform, to all Ovid customers globally. NRR is published by the publishing house of Neural Regeneration Research and <location>China</location> Science Press, and sponsored by the Chinese Rehabilitation Medical Association and supervised by China's Ministry of Health.</p>
<p/>
<p>"<location>China</location> is a strategic growth area for us, and we're especially excited to offer this prestigious title, Neural Regeneration Research, which publishes cutting-edge, evidence-based research and boasts a highly regarded and rigorous international editorial board," said <person>Karen Abramson</person>, President & CEO of Wolters Kluwer Health Medical Research. "Partnering on this initiative with our colleagues at Wolters Kluwer <location>China</location> has been absolutely critical to our success in working with the NRR team and <location>China</location> Science Press."</p>
<p/>
<p>Added <person>Lisha Wang</person>, Editor-in-Chief of Neural Regeneration Research, "Wolters Kluwer's global brand recognition and publishing innovation, combined with the strength of the OvidSP platform, widely recognized as a leading healthcare information search tool, will enable us to bring our content to the wider medical community around the world."</p>
<p/>
<p>Neural Regeneration Research (NRR) is renowned inside and outside of <location>China</location> for its dedication to publishing timely and practical original research and developments in the field of neuroregeneration, with contributions from experts in neuroanatomy, pathology, physiology, biochemistry, pharmacology, immunology, and auxanology. Topics include the influences of neural stem cells, neuroengineering, neurodegeneration, and traditional Chinese medicine and acupuncture intervention. NRR focuses on publishing meta-analysis articles with Chinese characteristics; evidence-based case clinical research articles; analysis of gene polymorphism related to region, nationality, and demography; review articles regarding new technology and new therapy; multi-center, large-sample, randomized, and controlled articles and reports; and more.</p>
<p/>
<p>The Journal's Editorial Committee is comprised of an international panel of academics to ensure that high quality is maintained. It has 92 international board members from 27 countries and 238 Chinese board members. Each manuscript is reviewed by 4-6 randomly selected editors. NRR boasts a rejection rate of 80% of submitted articles.</p>
<p/>
<p>NRR will be accessible on OvidSP's Journals@Ovid portal, which offers quick, easy access to approximately 1,200 premium and largely peer-reviewed journals in medicine and science--virtually none of which are embargoed. Significantly, users can search full-text articles via Journals@Ovid simultaneously with other e-resources for a streamlined, comprehensive search experience.</p>
<p/>
<p>See below for a cover image of the most recent issue (October) of Neural Regeneration Research:</p>
<pre>
    

    About Ovid and Wolters Kluwer Health
    
</pre>
<p>Ovid is a global information solutions provider offering clinicians, professionals, students, and researchers in the medical, scientific, and academic fields, customizable solutions of content, tools, and services that make research smarter, faster, and more effective. Ovid is used by the world's leading colleges and universities; medical schools; academic research libraries and library consortia; hospitals and healthcare systems; pharmaceutical, engineering and biotechnology companies; and HMOs and clinical practices.</p>
<p/>
<p>Ovid is a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy.  Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.</p>
<pre>
    





    

For further information: For further information: Robert Dekker, Director of Communications, Wolters Kluwer Health, +1-215-521-8928, Robert.Dekker@wolterskluwer.com, or Connie Hughes, Director, Marketing Communications, Wolters Kluwer Health - Medical Research, +1-646-674-6348, pressinfo@ovid.com

Organization Profile

WOLTERS KLUWER HEALTH

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890